Loading…
Kamada Ltd. is projected to rise to $9.37 by 2027, a +17% move from its current price of $7.98. KMDA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.83 | $7.98 | $8.14 | +0.04% |
| May 30 | $7.78 | $7.99 | $8.20 | +0.08% |
| May 31 | $7.73 | $7.99 | $8.25 | +0.12% |
| Jun 1 | $7.70 | $7.99 | $8.30 | +0.16% |
| Jun 2 | $7.66 | $8.00 | $8.34 | +0.19% |
| Jun 3 | $7.64 | $8.00 | $8.38 | +0.23% |
| Jun 4 | $7.61 | $8.00 | $8.41 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.61 | $8.00 | $8.41 | +0.27% |
| Week 2 | $7.48 | $8.02 | $8.61 | +0.54% |
| Week 3 | $7.38 | $8.05 | $8.77 | +0.82% |
| Week 4 | $7.30 | $8.07 | $8.91 | +1.09% |
| Week 5 | $7.23 | $8.09 | $9.05 | +1.37% |
| Week 6 | $7.18 | $8.11 | $9.17 | +1.64% |
| Week 7 | $7.13 | $8.13 | $9.28 | +1.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kamada Ltd. is a healthcare company that manufactures and sells plasma-derived protein therapeutics. Its product portfolio includes KAMRAB/KEDRAB for prophylaxis of rabies; CYTOGAM for CMV disease prophylaxis in kidney, lung, liver, pancreas, heart, and heart/lung transplant recipients; VARIZIG for post-exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence after liver transplants and for post-exposure prophylaxis; GLASSIA for intravenous alpha-1 antitrypsin deficiency treatment; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae antiserum for snake bites.
The company also distributes a broad range of biopharmaceutical products in Israel, including BRAMITOB, FOSTER, TRIMBOW, PROVOCHOLINE, AEROBIKA, RUPAFIN and RUPAFIN ORAL SOLUTION, IVIG, VARITECT for chickenpox and zoster, ZUTECTRA, HEPATECT CP, MEGALOTECT CP, RUCONEST, HEPARIN SODIUM INJECTION, ALBUMIN, Factor VIII, Factor IX, COAGADEX, IXIARO, VIVOTIF, PROCYSBI, LAMZEDE, RYPLAZIM and ELIGARD among others. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Kamada Ltd. (KMDA) is a healthcare company focused on plasma-derived protein therapeutics. It is currently priced at $7.83 with a market capitalization of $452.7M and a ranking position of 3114.
A major floor 11.1% below — a decisive break under it would weaken the trend.
The nearest floor, 4.8% below — buyers have tended to step in here.
The nearest ceiling, 7.1% above — a clean break opens room to run.
A major ceiling 16.7% above — clearing it would confirm fresh momentum.
Key KMDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KMDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.89 | Buy | $7.91 | Buy |
| MA 10 | $7.85 | Buy | $7.93 | Buy |
| MA 20 | $8.07 | Sell | $8.03 | Sell |
| MA 50 | $8.24 | Sell | $8.18 | Sell |
| MA 100 | $8.33 | Sell | $8.11 | Sell |
| MA 200 | $7.65 | Buy | $7.80 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.96 | Neutral |
| Stoch RSI (14) | 50.07 | Neutral |
| CCI (20) | -27.12 | Neutral |
| Williams %R (14) | -60.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.67 | Sell |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 40.00 | Neutral |
| TRIX (15) | -0.21 | Sell |
| Awesome (5,34) | -0.29 | Sell |
| Ultimate (7,14,28) | 56.96 | Neutral |
| Momentum (10) | -0.45 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 7.94 | Buy |
| ADX (14) | 12.74 | Neutral |
| ATR (14) | 0.13 | Info |
Technically, the stock shows a bullish sentiment with RSI(14) at 40. The 50-day simple moving average stands at $8.27 and the 200-day simple moving average is $7.64. Immediate support is at $7.60 and resistance at $8.55. Over the last 30 days, the trading range has been $6.87 to $8.92.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.03 | $7.98 | $10.40 | 0% | Neutral | |
| $7.66 | $9.37 | $12.01 | +17% | Neutral | |
| $8.29 | $10.33 | $13.58 | +29% | Bullish | |
| $10.15 | $12.84 | $17.24 | +61% | Bullish | |
| $11.67 | $14.96 | $20.44 | +88% | Bullish | |
| $12.45 | $16.15 | $22.42 | +102% | Bullish | |
| $12.88 | $16.90 | $23.79 | +112% | Bullish | |
| $13.23 | $17.55 | $25.01 | +120% | Bullish | |
| $14.84 | $19.88 | $28.67 | +149% | Bullish | |
| $16.63 | $22.48 | $32.78 | +182% | Bullish | |
| $22.85 | $32.23 | $49.23 | +304% | Bullish | |
| $46.50 | $70.32 | $115.13 | +781% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.03 | $7.98 | $9.33 | +0.00% |
| June 2026 | $6.95 | $8.10 | $9.64 | +1.56% |
| July 2026 | $7.05 | $8.27 | $9.92 | +2.01% |
| August 2026 | $6.93 | $8.17 | $9.87 | -1.23% |
| September 2026 | $6.90 | $8.17 | $9.94 | +0.03% |
| October 2026 | $7.12 | $8.45 | $10.34 | +3.46% |
| November 2026 | $7.18 | $8.55 | $10.51 | +1.22% |
| December 2026 | $7.06 | $8.43 | $10.40 | -1.49% |
Click any year to see its month-by-month KMDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The KMDA price prediction for 2026 points to an average of $7.98 (low $7.03, high $10.40) — a potential gain of 0% on today's $7.98. Price action looks broadly range-bound.
In 2027, KMDA is projected to trade between $7.66 and $12.01, averaging $9.37 — a potential gain of +17% from today's $7.98. That is up +17% on the projected 2026 average. A consolidation phase looks the most probable path here.
Kamada Ltd.'s 2028 outlook centres on $10.33, within a $8.29 to $13.58 range. That is up +10% on the projected 2027 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2029, KMDA could reach as high as $17.24, with a base case around $12.84 and support toward $10.15 — roughly +61% from $7.98. Buyers look set to stay in control over this stretch.
Expect KMDA to range from $11.67 to $20.44 through 2030. The $14.96 average target implies a +88% move from current prices. That is up +17% on the projected 2029 average. Momentum favours further upside here.
The KMDA price prediction for 2031 points to an average of $16.15 (low $12.45, high $22.42) — a potential gain of +102% on today's $7.98. Buyers look set to stay in control over this stretch.
In 2032, KMDA is projected to trade between $12.88 and $23.79, averaging $16.90 — a potential gain of +112% from today's $7.98. That is up +5% on the projected 2031 average. Momentum favours further upside here.
Kamada Ltd.'s 2033 outlook centres on $17.55, within a $13.23 to $25.01 range. That is up +4% on the projected 2032 average. That marks a +120% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, KMDA could reach as high as $28.67, with a base case around $19.88 and support toward $14.84 — roughly +149% from $7.98. Momentum favours further upside here.
Expect KMDA to range from $16.63 to $32.78 through 2035. The $22.48 average target implies a +182% move from current prices. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The KMDA price prediction for 2040 points to an average of $32.23 (low $22.85, high $49.23) — a potential gain of +304% on today's $7.98. Momentum favours further upside here.
In 2050, KMDA is projected to trade between $46.50 and $115.13, averaging $70.32 — a potential gain of +781% from today's $7.98. That is up +118% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in KMDA today (≈ 125.313283 KMDA) could be worth
$8,811.95
+$7,811.95 (+781%) by 2050 · US Dollar
Based on the average projected KMDA price of $70.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KMDAwould be worth at today's price.
$1,000 invested in KMDA on May 27, 2025 (≈ 143.884896 KMDA) would be worth
$1,148.2
+$148.2 (+14.8%) today · 1.15× · US Dollar
Based on a KMDA entry price of $6.95 vs. today's $7.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.87 | $1,013.98 | +1.4% |
| 1 month ago | $8.2 | $973.17 | -2.7% |
| 3 months ago | $8.91 | $895.62 | -10.4% |
| 6 months ago | $6.7 | $1,191.04 | +19.1% |
| 1 year ago | $6.95 | $1,148.2 | +14.8% |
| All time (5.0y) ago | $5.81 | $1,373.49 | +37.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KMDA forecast.
Our base-case forecast reaches $16.00 around 2031.
Implied market cap at $16.00: $922.98M
The multi-year forecast points to a longer uptrend, with the average price rising from $7.83 in 2026 to $70.34 in 2050. Key yearly averages are $7.83 (2026), $9.28 (2027), $10.18 (2028), $12.73 (2029), $14.91 (2030), $15.94 (2031), $16.75 (2032), $17.55 (2033), $19.72 (2034), $22.41 (2035), $32.08 (2040), and $70.34 (2050). Corresponding maximums and ROI figures show substantial upside, including a max of $20.53 in 2030 and a 2050 max of $116.89 with an impressive 798.4% ROI.
The forecast remains bullish through 2050, though actual outcomes will depend on market dynamics and company performance; these are estimates, not guarantees.
Tap a question to reveal the answer.
The forecast shows an avg price of $14.91, with a min of $11.55 and a max of $20.53; ROI is 90.4% and sentiment is BULLISH.
Forecasted averages rise over time with an avg of $9.28 in 2027 (ROI 18.5%) and $70.34 by 2050 (ROI 798.4%), with bullish sentiment from 2027 onward; however, 2026 shows an average of $7.83 with ROI 0 and these are estimates, not guarantees.
Yes. The 2030 max is $20.53 and the 2031 max is $22.31, indicating potential to surpass $20 in the forecast window.
The stock shows a bullish trajectory with a 30-day range of $6.87 to $8.92, a current price of $7.83, support at $7.60 and resistance at $8.55.
The forecast includes year-by-year variability, with 2026 showing ROI of 0% and notable volatility (annualized volatility 40%), and numbers are projections rather than guarantees.
Kamada Ltd. Community Discussion
0Share your Kamada Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.